πŸš€ Sensex Reclaims 82,000 as GST Relief Sparks Financial Rally

1–2 minutes

21-8-25

Indian equity markets extended their winning streak for the sixth straight session on Thursday, August 21, with the Sensex crossing back above the 82,000 mark. Gains were led by large-cap financial stocks after the GST panel proposed exempting taxes on health and life insurance premiums for individuals β€” a move welcomed by investors.

At the close:

Nifty 50: 25,083.75 (+33.20, +0.13%)

Sensex: 82,000.71 (+142.87, +0.17%)

The uptrend was supported by ICICI Bank, Reliance Industries, L&T, Bajaj Finance, and HDFC Bank, while caution persisted due to tariff risks despite optimism from GST reforms and an S&P upgrade.

πŸ”Ή Sectoral Performance

Out of 11 key Nifty sectoral indices, 5 advanced while 6 declined:

Top Gainer: Nifty Pharma (+0.95%) β€” lifted by Mankind Pharma & Cipla

Top Loser: Nifty FMCG (-0.64%) Broader Markets: Nifty Midcap 100 (-0.38%), Nifty SmallCap 100 (-0.01%)

πŸ’° FII & DII Flow (Cash Market, Aug 21, 2025)

FIIs: Net Buy β‚Ή1,125 crore DIIs: Net Sell β‚Ή643 crore

Foreign inflows drove large-cap momentum, while domestic investors booked profits in select counters.

🌍 Global Markets & Commodities

Dow Jones: Flat at 41,020 FTSE 100: +0.25% Nikkei 225: +0.62% Brent Crude: $81.4/barrel (marginal dip) Gold: $2,384/oz (steady) INR/USD: 83.24 (slightly weaker)

πŸ“… Global Economic Calendar (Aug 22, 2025)

Eurozone: Consumer Confidence (Aug) US: Existing Home Sales (Jul) Japan: CPI Inflation (Jul) UK: Retail Sales (Jul)

πŸ“Š Market Breadth & Internals (NSE) – Aug 21, 2025

Advances: 1,506

Declines: 1,476

Unchanged: 86

52-Week Highs: 82

52-Week Lows: 28

Upper Circuits: 99

Lower Circuits: 35

πŸ”Ž Today’s Top Volume Gainers (NSE)

ICICI Bank (+25.38 points contribution to Nifty) Reliance Industries (+17.61 points) Cipla (+5.90 points)

For educational use only. Not investment advice.

πŸ“Œ What This Means for Investors

Insurance stocks may stay in focus as GST exemption benefits individuals and boosts premium demand. Pharma momentum is likely to continue amid defensive positioning. Broader market caution signals selective accumulation in mid- & small-cap multibagger themes. FIIs are back with strong inflows β€” watch for sustained large-cap leadership.

πŸ‘‰ For more deep-dive analysis and actionable levels, catch our latest video on YouTube.

πŸ”— Explore our services: https://msha.ke/angeeras